Oh wow, not as impressive as I thought, but I guess we are looking at broad categories rather than specific types and variants. But overall the trend is down on ever cancer since around a decade ago. Was expecting a sharper drop around 1-2 decades ago, but things just take time when it comes to experimenting with human lives. Will be interesting to revisit this in another decade when a lot of the treatments finally leave the experimental stage.
Unfortunately, we actually don't make the kind of general widely applicable gains in treatment that people believe we have. We're not in a much different place for major cancers than we were 30 years ago, and I don't see much value in assuming we will just suddenly improve.